Skip to main content

Closed

ABEO: Abeona Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-637.9%

ROIC-50.9%

Financially safe

Stretched

Debt / equity0.16×

Interest coverage-26.0×

Current ratio5.89×

Valuation

Unrated

P/E ratio5.0×

Abeona Therapeutics Inc.

ABEONASDAQ Capital Market·USD·Closed

Abeona Therapeutics Inc.

ABEONASDAQ·USD·Closed

$6.42

−0.77%

$6.42

−$0.05 (0.77%)

52W Range

68thpctl

Volume

0.52×avg

Mkt Cap

365.91MUSD

P/E

5.0TTM

Div Yield

–ann

52W Range

68thpctl

Volume

0.52×avg

Market Cap

365.91MUSD

P/E Ratio

5.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings